The backdrop of the research highlights an increasing prevalence of ADHD globally, with recent estimates suggesting that around 5% of children worldwide are diagnosed with this neurodevelopmental disorder. Conventional treatments often include a combination of behavioral therapy and stimulant medications, which have proven effective but also come with a range of side effects, leading many families to explore alternative options. East Asian traditional medicine offers a unique perspective that diverges significantly from the Western medical paradigm, focusing on restoring balance within the body’s natural systems.

In the review, Lee and Sung delve into specific traditional practices prevalent in countries such as China, Korea, and Japan. Acupuncture, for example, has gained attention as a method that may enhance cognitive functions and reduce hyperactivity. Some studies indicated that acupuncture could influence the release of neurotransmitters, thereby improving concentration and behavioral control. Moreover, the practice of moxibustion—a technique involving the burning of mugwort herb near acupuncture points—has been highlighted in several anecdotal reports, suggesting potential benefits in behavioral modulation.

Herbal medicine constitutes another cornerstone of East Asian traditional practices. The authors of the review enumerate various herbal formulations that have shown promise in alleviating ADHD symptoms. For instance, specific combinations of ginseng, gingko biloba, and other herbs have been employed to improve focus and reduce impulsivity. Each herb possesses individual pharmacological properties that can work synergistically, leveraging benefits that may not be realized through single-component interventions.

Additionally, the practice of Tai Chi, a traditional martial art known for its meditative movements, has been explored for its potential impact on attention and behavioral disorders. The slow and deliberate nature of Tai Chi may help children with ADHD develop self-regulation skills, improve bodily awareness, and promote relaxation—all of which are essential components for managing ADHD symptoms. The integration of physical activity with mindfulness exemplifies the holistic approach inherent in East Asian traditional medicine.

The review also critically assesses the current state of research surrounding these practices, noting that, while many anecdotal reports and preliminary studies suggest benefits, there is a significant need for rigorous clinical trials to establish efficacy reliably. Randomized controlled trials are necessary to discern the specific effects of traditional treatments, control for placebo effects, and address the complex interactions between various modalities of treatment.

Moreover, the cultural context of East Asian traditional medicine plays an essential role in its acceptance and utilization. In societies where these practices are deeply embedded in the healthcare system, patients often report a sense of belonging and cultural resonance in their treatment choices. This psychological component can enhance treatment adherence and patient satisfaction, presenting an intriguing area for further exploration in cross-cultural health studies.

However, Lee and Sung emphasize the importance of practitioner qualification and safety, as unregulated practices may pose risks. The need for standardized training among practitioners of traditional medicine and adherence to safety protocols are crucial to ensure that children receive beneficial and safe treatments.

Looking ahead, the potential for integrating East Asian traditional medical practices with conventional ADHD treatments offers an exciting frontier for research and clinical practice. By fostering a multidisciplinary approach that embraces various treatment modalities, healthcare practitioners can better serve the diverse needs of children and families coping with ADHD.

Moreover, the review calls for increased governmental support for research funding in alternative medicine studies, recognizing that many families may gravitate towards these options for perceived safety and holistic benefits. As societal perspectives on alternative medicine continue to evolve, it becomes imperative for the scientific community to engage in meaningful dialogues with traditional practitioners, paving the way for integrative treatment protocols.

This scoping review serves as a foundation for future research efforts that could unravel the complexities of ADHD management through traditional lenses. By systematically cataloging existing practices and scientific inquiries, Lee and Sung present a blueprint for further inquiry, bridging the gap between ancient wisdom and modern scientific validation.

As excitement grows around alternative treatments for ADHD, researchers, practitioners, and families alike will undoubtedly benefit from increased awareness and understanding of East Asian traditional medicine’s potential role. The landscape of ADHD treatment is poised for a transformation that honors both heritage and innovation, with a goal of ultimately improving lives and fostering healthier futures for children and adolescents facing the challenges of ADHD.

As this review illustrates, the journey into the heart of traditional medicine is one filled with possibility, as various cultures have long recognized that health is often a multifaceted pursuit. The integration of East Asian traditional medicine into ADHD treatment paradigms could not only widen therapeutic options but also invite a renewed sense of agency among families navigating this complex condition.

In conclusion, the exploration of non-pharmaceutical interventions, particularly through the lens of East Asian traditional practices, enlightens the conversation surrounding ADHD treatment. Embracing a variety of methodologies empowers practitioners and families alike to collaborate in discovering holistic solutions that align with their specific needs, cultivating a landscape where the synergy of various treatment options can flourish.

Subject of Research: East Asian traditional medicine for attention-deficit hyperactivity disorder in children and adolescents.

Article Title: East Asian traditional medicine for attention-deficit hyperactivity disorder in children and adolescents: a scoping review.

Article References: Lee, J., Sung, HK. East Asian traditional medicine for attention-deficit hyperactivity disorder in children and adolescents: a scoping review. BMC Complement Med Ther 25, 399 (2025). https://doi.org/10.1186/s12906-025-05119-y

Image Credits: AI Generated

DOI: https://doi.org/10.1186/s12906-025-05119-y

Keywords: ADHD, East Asian traditional medicine, acupuncture, herbal medicine, Tai Chi, alternative treatments.

The study published in the journal Neuropsychopharmacology presents compelling evidence from animal models, suggesting that amlodipine can significantly reduce hyperactive behaviors in ADHD-like symptomatology. This was primarily tested on specially bred rats that exhibited behavior akin to individuals with ADHD. Remarkably, amlodipine emerged as the only drug among five candidates to noticeably minimize hyperactivity levels in these animal models, marking a critical discovery for future research in ADHD treatment.

Building on these encouraging results, the researchers conducted further experiments using zebrafish, an established model for neurobiology due to their genetic similarities to humans, sharing approximately 70% of their genes. The choice of zebrafish allowed for advanced investigation into amlodipine’s action mechanisms. The outcomes were consistent with the prior findings, demonstrating that amlodipine also effectively reduced hyperactivity and impulsivity in the fish, thereby reinforcing the potential for its application in treating ADHD in humans.

One of the significant discoveries made during this research was the compound’s ability to cross the blood-brain barrier. This pivotal finding suggests that amlodipine could exert direct effects on brain function, primarily targeting the neural pathways associated with hyperactivity and impulsivity. Cross-examination of zebrafish responses demonstrated enhanced behavioral regulation when exposed to amlodipine, indicating its necessary neuropharmacological action inside the central nervous system.

Delving deeper into the genetic underpinnings associated with ADHD, the research team discovered a remarkable correlation between ADHD and calcium channels in the brain, which are the same pathways targeted by amlodipine. This connection is critical as it provides valuable insights that help in identifying potential neural circuits that are impaired in individuals with ADHD, thereby indicating that amlodipine could be functioning through a novel mechanism that has yet to be fully understood.

Additionally, an analysis of extensive patient data across the UK highlighted a noticeable trend where individuals taking amlodipine reported fewer mood fluctuations and exhibited less risk-taking behavior. This emerging evidence not only strengthens the case for amlodipine as a potential ADHD treatment but also underscores its safety profile compared to traditional ADHD medications, which can frequently lead to adverse effects including appetite suppression, elevated blood pressure, and sleep disturbances.

Dr. Matthew Parker, a co-author of the study from the University of Surrey, has emphasized the transformative potential of repurposing established medications like amlodipine. He notes that the existing approval status and a well-acknowledged safety profile would allow amlodipine to be deployed swiftly for ADHD treatment, potentially providing relief to patients who currently face limited options due to the complexities of prevalent treatment therapies and their side effects.

The findings of this research carry significant implications as approximately 25% of patients do not respond adequately to conventional ADHD therapies, a concerning statistic that highlights the urgent demand for safer, more effective alternatives. As the global prevalence of ADHD continues to rise, innovative strategies such as repurposing medications like amlodipine could emerge as key solutions in addressing treatment gaps and enhancing life quality for those suffering from this disorder.

The prospect of using amlodipine not only enriches therapeutic avenues available for ADHD but also opens up questions regarding the broader implications of drug repurposing in psychiatric ailments. Investigating and uncovering existing drugs’ potential to treat mental health disorders can accelerate drug discovery processes and significantly reduce the time and resource investment needed to develop new pharmacological agents, a significant advantage in both clinical settings and healthcare systems overall.

As research progresses, the collaboration between neuroscientists and pharmacologists will be crucial in elucidating the precise mechanisms through which amlodipine operates. Future studies may expand on whether combined therapies or dosage adjustments could further enhance treatment efficacy for patients suffering from the diverse manifestations of ADHD. Ongoing studies and rigorous clinical trials will be necessary to cement amlodipine’s position as an impactful treatment option for ADHD.

In summary, the innovative approach of repurposing amlodipine proposes a refreshing outlook on ADHD management, challenging preconceived notions of existing treatment paradigms. The research not only expands medical understanding of ADHD but also inspires a broader discourse on the potential for existing medications to be harnessed in novel contexts, significantly shifting the landscape of mental health treatment paradigms. As the scientific community amplifies investigations in this direction, the promise of unlocking therapeutic potential from established drugs gives new hope to patients seeking effective measures in managing ADHD and its challenges.

Subject of Research: The potential of amlodipine, a blood pressure medication, as a treatment for ADHD.
Article Title: Blood pressure drug could be a safer alternative for treating ADHD symptoms, finds study
News Publication Date: Date not specified in the provided text.
Web References: Neuropsychopharmacology
References: Study details available in the journal Neuropsychopharmacology.
Image Credits: Not specified in the provided text.
Keywords: ADHD, amlodipine, blood pressure medication, calcium channels, neuropsychopharmacology, treatment options, mental health, drug repurposing, zebrafish, animal models, impulsivity, hyperactivity.